Improvements in Real‑World Survival in the Setting of a Recent Paradigm Shift in Acute Myeloid Leukemia Treatment
Acute myeloid leukemia (AML) is a disease of the elderly
The overall survival of patients with newly diagnosed acute myeloid leukemia (AML) has improved in the recent years, associated with the increased use of hypomethylating agent‑based therapies and a shift away from conventional intensive chemotherapy.
This demonstrates a meaningful shift in AML treatment patterns associated with improved outcomes overall, but an ongoing lack of progress in the highest‑risk subgroups.
Evidence level: Megerősített klinikai bizonyíték. Több vagy erősebb humán vizsgálat támogatja.
Related signals
- Management of Acute Myeloid Leukemia: A Review
- Old cells, new tricks—important clue to AML diagnosis and cure discovered
- Treatment of Acute Myeloid Leukaemia
- Effective eradication of acute myeloid leukemia stem cells with FLT3-directed antibody-drug conjugates
- Research blog: Accelerating progress in AML